Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Variants in common genes linked to endometrial cancer risk

Publish date:: February 21, 2020

Key clinical point: Certain genetic variants may be linked to a greater risk of developing endometrial cancer.

Major finding: An analysis revealed 24 independent single-nucleotide polymorphisms that were associated with a higher risk of endometrial cancer.

Study details: A systematic review of 149 studies evaluating associations between genetic polymorphisms and endometrial cancer risk.

Disclosures: The National Institute for Health Research Manchester Biomedical Research Centre funded the study. The authors declared no conflicts of interest.

Citation:

Bafligil C et al. J Med Genet. 2020 Feb 17. doi: 10.1136/jmedgenet-2019-106529.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Gynecologic Cancer

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

Is diagnostic hysteroscopy safe in patients with type 2 endometrial cancer?,

Cervical cancer recurrence patterns differ after laparoscopic and open hysterectomy,

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest,

Half of women treated for gynecologic cancers miss or skip doses of oral drugs,